Psoriasis Treatment Changes the Expression Profile of Selected Caspases and their Regulatory MicroRNAs

Background/Aims: Psoriasis, an autoimmune diseases of the skin, characterized by patches of abnormal/inflammed skin, although not usually life-threatening, it causes severe discomfort, esthetic impairments, and may lead to impaired social functions and social withdrawal. Besides UV-phototherapy, var...

Full description

Saved in:

Bibliographic Details
Published in:	Cellular physiology and biochemistry Vol. 50; no. 2; pp. 525 - 537
Main Authors:	Wcisło-Dziadecka, Dominika, Simka, Klaudia, Kaźmierczak, Agata, Kruszniewska-Rajs, Celina, Gola, Joanna, Grabarek, Beniamin, Hybiak, Jolanta, Grillon, Catherine, Mazurek, Urszula, Łos, Marek J.
Format:	Journal Article
Language:	English
Published:	Basel, Switzerland S. Karger AG 01.10.2018 Karger Cell Physiol Biochem Press GmbH & Co KG
Subjects:	adalimumab Adalimumab - pharmacology Adalimumab - therapeutic use Apoptosis Autoimmune diseases Autophagy Biochemistry Biochemistry, Molecular Biology Cancer Caspase Caspases - genetics Caspases - metabolism Cell adhesion & migration Cell Behavior Cell growth Cell Line Cellular Biology Clinical Computational Biology Dermatology Disease Enzymes Exemptia Fibroblasts - cytology Fibroblasts - drug effects Fibroblasts - metabolism Gene expression Human health and pathology Humans Humira Immunotherapy Inflammatory diseases Inflammosome Life Sciences Metabolism Micro-RNA MicroRNAs MicroRNAs - metabolism Monoclonal antibodies Oligonucleotide Array Sequence Analysis Original Paper Psoriasis Psoriasis - drug therapy Psoriasis - genetics Psoriasis - pathology Rheumatoid arthritis Subcellular Processes Time Factors TNF inhibitors Transcriptome - drug effects Tumor necrosis factor-TNF Psoriasis Inflammosome Caspase Micro-RNA Clinical Humira Exemptia adalimumab
ISSN:	1015-8987, 1421-9778, 1421-9778
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!